These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 26071410)

  • 1. Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.
    Hicks LC; Huang J; Kumar S; Powles ST; Orchard TR; Hanna GB; Williams HR
    J Crohns Colitis; 2015 Sep; 9(9):731-7. PubMed ID: 26071410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive exhaled volatile organic biomarker analysis to detect inflammatory bowel disease (IBD).
    Arasaradnam RP; McFarlane M; Daulton E; Skinner J; O'Connell N; Wurie S; Chambers S; Nwokolo C; Bardhan K; Savage R; Covington J
    Dig Liver Dis; 2016 Feb; 48(2):148-53. PubMed ID: 26682719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentane and other volatile organic compounds, including carboxylic acids, in the exhaled breath of patients with Crohn's disease and ulcerative colitis.
    Dryahina K; Smith D; Bortlík M; Machková N; Lukáš M; Španěl P
    J Breath Res; 2017 Nov; 12(1):016002. PubMed ID: 28781264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study.
    Patel N; Alkhouri N; Eng K; Cikach F; Mahajan L; Yan C; Grove D; Rome ES; Lopez R; Dweik RA
    Aliment Pharmacol Ther; 2014 Sep; 40(5):498-507. PubMed ID: 25041596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry.
    Monasta L; Pierobon C; Princivalle A; Martelossi S; Marcuzzi A; Pasini F; Perbellini L
    PLoS One; 2017; 12(8):e0184118. PubMed ID: 28859138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing Inflammatory bowel disease using noninvasive applications of volatile organic compounds: a systematic review.
    Bannaga AS; Farrugia A; Arasaradnam RP
    Expert Rev Gastroenterol Hepatol; 2019 Nov; 13(11):1113-1122. PubMed ID: 31657950
    [No Abstract]   [Full Text] [Related]  

  • 7. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma.
    Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB
    Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease.
    van Gaal N; Lakenman R; Covington J; Savage R; de Groot E; Bomers M; Benninga M; Mulder C; de Boer N; de Meij T
    J Breath Res; 2017 Nov; 12(1):016006. PubMed ID: 28439048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
    Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
    World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease.
    Ahmed I; Greenwood R; Costello B; Ratcliffe N; Probert CS
    Aliment Pharmacol Ther; 2016 Mar; 43(5):596-611. PubMed ID: 26806034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease-A Pilot Study.
    Tiele A; Wicaksono A; Kansara J; Arasaradnam RP; Covington JA
    Biosensors (Basel); 2019 Apr; 9(2):. PubMed ID: 31013848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Selected Ion Flow Tube-Mass Spectrometry Technology to Identify Breath Volatile Organic Compounds for the Detection of Head and Neck Squamous Cell Carcinoma: A Pilot Study.
    Chandran D; Ooi EH; Watson DI; Kholmurodova F; Jaenisch S; Yazbeck R
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31242578
    [No Abstract]   [Full Text] [Related]  

  • 13. The faecal scent of inflammatory bowel disease: Detection and monitoring based on volatile organic compound analysis.
    Bosch S; Wintjens DSJ; Wicaksono A; Kuijvenhoven J; van der Hulst R; Stokkers P; Daulton E; Pierik MJ; Covington JA; de Meij TGJ; de Boer NKH
    Dig Liver Dis; 2020 Jul; 52(7):745-752. PubMed ID: 32402741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn's Disease: A Metabolomic Approach.
    Bodelier AG; Smolinska A; Baranska A; Dallinga JW; Mujagic Z; Vanhees K; van den Heuvel T; Masclee AA; Jonkers D; Pierik MJ; van Schooten FJ
    Inflamm Bowel Dis; 2015 Aug; 21(8):1776-85. PubMed ID: 26199990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis.
    Smolinska A; Bodelier AG; Dallinga JW; Masclee AA; Jonkers DM; van Schooten FJ; Pierik MJ
    Aliment Pharmacol Ther; 2017 May; 45(9):1244-1254. PubMed ID: 28239876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
    von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
    Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer.
    Kumar S; Huang J; Abbassi-Ghadi N; Španěl P; Smith D; Hanna GB
    Anal Chem; 2013 Jun; 85(12):6121-8. PubMed ID: 23659180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of pentane in exhaled breath, a potential biomarker of bowel disease, using selected ion flow tube mass spectrometry.
    Dryahina K; Španěl P; Pospíšilová V; Sovová K; Hrdlička L; Machková N; Lukáš M; Smith D
    Rapid Commun Mass Spectrom; 2013 Sep; 27(17):1983-92. PubMed ID: 23939966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal volatile organic compounds differ according to inflammatory bowel disease sub-type, severity, and response to treatment in paediatric patients.
    Belnour S; Slater R; Tharmaratnam K; Karl-Heinz Auth M; Muhammed R; Spray C; Wang D; Zeeshan Ijaz U; Probert C; Allen S
    United European Gastroenterol J; 2024 Jul; 12(6):780-792. PubMed ID: 38922802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.